What question did this study set out to answer?

This analysis aims to investigate the defective TXA2-induced platelet aggregation and its underlying mechanisms.

Pathogenetic Analysis of Five Cases with a Platelet Disorder Characterized by the Absence of Thromboxane A2(TXA2)-Induced Platelet Aggregation in Spite of Normal TXA2 Binding Activity

View Full Paper

Ask AI

Bookmark

Authors

Case report demonstrates defective platelet aggregation in patients with TXA2 signaling impairment, suggesting heterogeneous disorder mechanisms.

This analysis aims to investigate the defective TXA2-induced platelet aggregation and its underlying mechanisms.
Presented five cases with mild bleeding tendencies and examined TXA2-induced platelet responses.
Assessed binding activity of exogenous TXA2 and evaluated signaling pathways in response to synthetic TXA2 mimetics.
Analyzed outcomes including IP3 formation, Ca2+ mobilization, and GTPase activities.
Normal TXA2 binding activity in all patients despite defective TXA2-induced aggregation.
Markedly prolonged bleeding time in one patient.
Selectively defective synthetic TXA2 mimetic-induced responses observed in three patients, indicating heterogeneous disorder mechanisms.

Fuse et al. (1996) studied this question.

View Full Paper

Ask AI

Bookmark

Case report demonstrates defective platelet aggregation in patients with TXA2 signaling impairment, suggesting heterogeneous disorder mechanisms.